1-9 of 9
Sung-Eun Lee, M.D.
Close
Sort by
Journal Articles

Plasma Imatinib Trough Level Is a Predictor For 3-Month Early Molecular Response In New CP CML Patients

Sung-Eun Lee, M.D., Soo Young Choi, Soo-Hyun Kim, Yun Jeong Oh, Jin-Eok Park, Eun-Jung Jang, Dong-Wook Kim, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2716.
https://doi.org/10.1182/blood.V122.21.2716.2716
Published: 2013
Journal Articles

Kinetics Of Low-Level Mutant Clones Detected By Subcloning and Sequencing In Tyrosine Kinase Inhibitor Resistant CML

Soo-Hyun Kim, Soo Young Choi, Sung-Eun Lee, M.D., Yun Jeong Oh, Jin-Eok Park, Hae Lyun Yoo, Hye-Rim Jeon, Eun-Jung Jang, Dong-Wook Kim, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2720.
https://doi.org/10.1182/blood.V122.21.2720.2720
Published: 2013
Journal Articles

Impact Of The Early Intensification Of Induction Chemotherapy On Complete Remission and Survival Rates For De Novo Adult Acute Myeloid Leukemia

Seung-Ah Yahng, Jae-Ho Yoon, MD, Sung-Eun Lee, M.D., Seung-Hwan Shin, Byung-Sik Cho, Ki-Sung Eom, Yoo-Jin Kim, Seok Lee, MD, PhD, Chang-Ki Min, Seok-Goo Cho, Dong-Wook Kim, MD, Jong-Wook Lee, Woo-Sung Min, Chong-Won Park, Heeje Kim
Journal: Blood
Blood (2013) 122 (21): 3402.
https://doi.org/10.1182/blood.V122.21.3402.3402
Published: 2013
Journal Articles

Safety and Efficacy Of Imatinib In Elderly Patients With Chronic-Phase Chronic Myeloid Leukemia: Analysis Of Outcome For < 60 Years Versus ≥ 60 Years

Young-Woong Won, M.D., Ph.D., DongWook Kim, Sung-Eun Lee, M.D., Soo Young Choi, Soo-Hyun Kim, Eun-Jung Jang
Journal: Blood
Blood (2013) 122 (21): 4039.
https://doi.org/10.1182/blood.V122.21.4039.4039
Published: 2013
Journal Articles

Predictive Factors For An Achievement Of 6-Month Early Molecular Response In New CP CML Patients Treated With Imatinib

Sung-Eun Lee, M.D., Soo Young Choi, Soo-Hyun Kim, Yun Jeong Oh, Jin-Eok Park, Eun-Jung Jang, Dong-Wook Kim, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5160.
https://doi.org/10.1182/blood.V122.21.5160.5160
Published: 2013
Journal Articles

Six-Year Follow-Up Of Dasatinib-Related Pulmonary Arterial Hypertension (PAH) For Chronic Myeloid Leukemia In Single Center

Young-Woo Jeon, M.D., Sung-Eun Lee, M.D., Soo-Hyun Kim, Soo-Young Choi, Jin-Eok Park, Hye-Rim Jeon, Eun-Jung Jang, Dong-Wook Kim, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4017.
https://doi.org/10.1182/blood.V122.21.4017.4017
Published: 2013
Journal Articles

Peripheral Arterial Occlusive Disease (PAOD) In Chronic Phase Chronic Myeloid Leukemia Patients Treated With Nilotinib

Young-Woo Jeon, M.D., Sung-Eun Lee, M.D., Soo-Young Choi, Soo-Hyun Kim, Jin-Eok Park, Hye-Rim Jeon, Eun-Jung Jang, Dong-Wook Kim, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4018.
https://doi.org/10.1182/blood.V122.21.4018.4018
Published: 2013
Journal Articles

Nilotinib Or High-Dose Imatinib Compared With Standard-Dose Imatinib In Early Chronic Phase CML Patients Who Have Suboptimal Molecular Responses To Standard-Dose Imatinib: Including Updated Data From RE-Nice Study

Soo-Young Choi, Sung-Eun Lee, M.D., Yun Jeong Oh, Soo-Hyun Kim, Richard C. Woodman, Tomasz Szczudlo, Saengsuree Jootar, MD, Hyeoung-Joon Kim, MD, PhD, Sang Kyun Sohn, MD, PhD, Joon Seong Park, MD, Sung-Hyun Kim, MD, PhD, Dae-Young Zang, Suk-Joong Oh, Dong-Wook Kim, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1499.
https://doi.org/10.1182/blood.V122.21.1499.1499
Published: 2013
Journal Articles

Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome with a Reduced Intensity Conditioning Regimen Consisting of Intravenous Busulfan, Fludarabine, and 400 Cgy Total Body Irradiation.

Sung Eun Lee, M.D, Yoo Jin Kim, MD, Seok Goo Cho, Byung Sik Cho, Ki-Seong Eom, Hee Je Kim, Seok Lee, Chang-Ki Min, MD, Dong Wook Kim, Jong Wook Lee, Woo Sung Min, Chong Won Park, Chun Choo Kim
Journal: Blood
Blood (2009) 114 (22): 4327.
https://doi.org/10.1182/blood.V114.22.4327.4327
Published: 2009